A new study reveals that diabetes significantly impacts the emotional well-being of 70% of patients in Brazil [1].

These findings highlight a critical gap in chronic disease management, suggesting that physical treatment alone is insufficient without integrated mental health support.

The research was conducted by the Global Wellness Institute in partnership with Roche Diagnostics to quantify the emotional burden of the disease [2]. The data shows that 78% of patients report experiencing anxiety or specific concerns regarding their future [1].

Social isolation also emerges as a primary challenge for those living with the condition. According to the study, 40% of patients, or two in five individuals, feel lonely or isolated [1]. This emotional strain varies across different forms of the disease, with a higher concentration of distress found among certain groups.

Specifically, 77% of patients with type 1 diabetes report a greater emotional impact compared to the general diabetic population [1]. The study was released in 2024 to bring attention to the psychological toll of managing the condition in Brazil [2].

Healthcare providers said that the daily demands of glucose monitoring and medication adherence can contribute to this mental fatigue. The high percentage of patients reporting anxiety suggests that the fear of long-term complications remains a dominant factor in the patient experience [1].

“70% of patients in Brazil report that diabetes significantly impacts their emotional well-being.”

The data suggests that diabetes in Brazil is not merely a metabolic challenge but a psychological one. With nearly 80% of patients facing anxiety and a significant portion of type 1 diabetics reporting higher emotional distress, the results indicate a need for a multidisciplinary approach to care that combines endocrinology with mental health services to improve long-term patient outcomes.